Last reviewed · How we verify
NCT06653595: PAP-LM
Breastfeeding Support and Promotion Program to Improve the Health of Premature Babies (PAP-LM)
NA trial testing Programme to Support Breastfeeding in Prematurity; Extreme in 162 participants. Completed in 20 March 2024.
15 February 2024
Quick facts
| Lead sponsor | University of Barcelona |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 162 |
| Start date | 13 October 2021 |
| Primary completion | 15 February 2024 |
| Estimated completion | 20 March 2024 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- Programme to Support Breastfeeding
Conditions studied
- Prematurity; Extreme — all drugs for Prematurity; Extreme →
- Prematurity — all drugs for Prematurity →
Sponsor
University of Barcelona
Who can join
18 and older, female only, with Prematurity; Extreme or Prematurity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effectiveness of a breastfeeding support and promotion program to increase exclusive breastfeeding rates in the preterm group. The intervention is performed by an Advanced Practice Nurse and International Board Certified Breastfeeding Consultant (IBCLC), with high expertise in breastfeeding problems. It is a combination of face-to-face, home care and telephone attention to improve the adherence to breastfeeding. The intervention lasts 6 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06653595
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prematurity; Extreme
Currently open trials in the same condition.
- NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting
- NCT06557551 — Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial · NA · recruiting
- NCT04735315 — Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study · active not recruiting
- NCT04545866 — The Budesonide in Babies (BiB) Trial · Phase 3 · active not recruiting
- NCT04325308 — Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk · NA · active not recruiting
Other University of Barcelona trials
Trials by the same sponsor.
- NCT07165964 — Nursing Interventions to Enhance Positive Mental Health and Self Care in Women During the Climacteric · NA · recruiting
- NCT06384196 — Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression · NA · recruiting
- NCT06729697 — Pharmaceutical Literacy and Quality of Life in Spanish Population. · enrolling by invitation
- NCT06478160 — Closed-blood Sampling Devices in the Adult Critically Ill Patient · NA · recruiting
- NCT07172490 — Interdisciplinary Program to Improve Lifestyle in Chronic Pathology: Alt Pirineu Aran in Fit (APA-FIT) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06653595 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Barcelona
- Last refreshed: 22 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06653595.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing